Back to Search Start Over

Dermatology: how to manage facial hyperpigmentation in skin of colour.

Authors :
Moolla S
Miller-Monthrope Y
Source :
Drugs in context [Drugs Context] 2022 May 31; Vol. 11. Date of Electronic Publication: 2022 May 31 (Print Publication: 2022).
Publication Year :
2022

Abstract

Hyperpigmentation disorders, such as post-inflammatory hyperpigmentation and melasma, are common conditions affecting all skin types. These conditions are largely benign and are influenced by numerous endogenous and exogenous factors impacting melanocyte activity and melanin production. Current treatment modalities for these conditions fall into broad categories, including photoprotection, topical and systemic therapies, chemical peels, and laser or light-based therapies. Biological differences in skin of colour require additional consideration when deciding on treatment and management. This narrative review provides an inclusive summary of these conditions and compares the current treatment options with a specific focus on skin of colour. Photoprotection and sunscreens protective against both UV and visible light are recommended for all individuals. Topical therapy is the recommended first-line treatment, with the gold standard being hydroquinone, which can be used alone or in combination with other agents. Chemical peels and laser or light-based therapies are also effective adjunctive methods of treatment; however, caution should be taken when used in patients with richly pigmented skin due to the increased risk of post-inflammatory hyperpigmentation.<br />Competing Interests: Disclosure and potential conflicts of interest: The authors declare that they have no conflicts of interest relevant to this manuscript. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2022/05/dic.2021-11-2-COI.pdf<br /> (Copyright © 2022 Moolla S, Miller-Monthrope Y.)

Details

Language :
English
ISSN :
1745-1981
Volume :
11
Database :
MEDLINE
Journal :
Drugs in context
Publication Type :
Academic Journal
Accession number :
35720052
Full Text :
https://doi.org/10.7573/dic.2021-11-2